Lineage Cell Therapeutics Inc (NYSE American:LCTX)
| 1.30 Delayed Data As of May 26 |  +0.02 / +1.56%Today’s Change | 1.02 Today|||52-Week Range 1.79 | +11.11% Year-to-Date |
Institutional investors purchased a net $4.2 million shares of LCTX during the quarter ended June 2019 and now own 46.65% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Mutual fund holders | 9.15% |
| Other institutional | 37.50% |
| Individual stakeholders | 25.14% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2023 | BANK OF AMERICA, NA (PRIVATE BAN... Bought 1.3 Million shares of Lineage Cell Therapeutics... |
| 3/31/2023 | MILLENNIUM MANAGEMENT LLC Bought 1.0 Million shares of Lineage Cell Therapeutics... |
| 3/31/2023 | SUSQUEHANNA FINANCIAL GROUP LLLP Bought 642.8 Thousand shares of Lineage Cell Therapeutics... |
Top 10 Owners of Lineage Cell Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Broadwood Capital, Inc. | 20.53% | 34,935,485 | 47,512,260 | 0 | 0.00% |
| Greenway Partners LP | 4.03% | 6,849,242 | 9,314,969 | 0 | 0.00% |
| The Vanguard Group, Inc. | 3.80% | 6,459,293 | 8,784,638 | +397,884 | +6.56% |
| Defender Capital LLC | 3.02% | 5,136,085 | 6,985,076 | +42,550 | +0.84% |
| BlackRock Fund Advisors | 2.16% | 3,679,968 | 5,004,756 | -74,234 | -1.98% |
| Laurion Capital Management LP | 1.40% | 2,377,940 | 3,233,998 | 0 | 0.00% |
| Prescott Investors, Inc. | 1.09% | 1,851,851 | 2,518,517 | 0 | 0.00% |
| Raffles Capital Management LLC | 0.90% | 1,536,946 | 2,090,247 | 0 | 0.00% |
| British & American Investment Tru... | 0.86% | 1,461,951 | 1,988,253 | -809,102 | -35.63% |
| Millennium Management LLC | 0.82% | 1,402,123 | 1,906,887 | +1,003,084 | +251.37% |
Top 10 Mutual Funds Holding Lineage Cell Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF | 2.66% | 4,523,730 | 6,152,273 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 1.00% | 1,707,356 | 2,322,004 | 0 | 0.00% |
| British & American Investment Tru... | 0.86% | 1,461,951 | 1,988,253 | -809,102 | -35.63% |
| iShares Biotechnology ETF | 0.74% | 1,254,937 | 1,706,714 | -2,084 | -0.17% |
| JPMorgan Funds - Thematics - Gene... | 0.56% | 960,512 | 1,306,296 | -296,219 | -23.57% |
| Fidelity Extended Market Index Fu... | 0.40% | 688,031 | 935,722 | 0 | 0.00% |
| KSM ETF (4A) TA-SME60 | 0.35% | 590,919 | 803,650 | +219,045 | +58.90% |
| Bridgeway Ultra Small Company Mar... | 0.26% | 442,900 | 602,344 | 0 | 0.00% |
| DekaLux - BioTech | 0.22% | 365,500 | 497,080 | -184,500 | -33.55% |
| Bridgeway Ultra Small Company Fun... | 0.19% | 324,200 | 440,912 | 0 | 0.00% |